# The Neuropsychology of Chronic Neurological Disorders: A Review of Cognitive and Emotional Impairments

**Authors:** Harsh S, Haseeb Javaid Rather, Amitabh Dwivedi, Suman Bala, P. Velladurai, Seethalakshmy Anantharaman

PMC · DOI: 10.7759/cureus.93642 · Cureus · 2025-10-01

## TL;DR

This review explores how chronic neurological disorders affect cognitive and emotional functions, emphasizing the need for comprehensive and personalized care.

## Contribution

The paper provides a synthesis of current evidence on cognitive and emotional impairments in chronic neurological disorders and highlights emerging assessment and intervention strategies.

## Key findings

- Cognitive domains like memory and executive function are commonly impaired in chronic neurological disorders.
- Emotional disturbances such as depression and anxiety are closely linked to cognitive deficits in these disorders.
- Multidisciplinary and patient-centered approaches are essential for improving quality of life in affected individuals.

## Abstract

Chronic neurological disorders (CNDs) represent a broad spectrum of conditions, including Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, stroke, and traumatic brain injury that significantly impair cognitive and emotional functioning. These neuropsychological deficits are not merely ancillary to neurological deterioration but are core features that profoundly affect daily living and long-term outcomes. This review synthesizes current evidence on the cognitive domains most commonly affected, such as memory, attention, executive function, and language, and the spectrum of emotional disturbances, including depression, anxiety, apathy, and mood dysregulation. By examining disorder-specific profiles, neurobiological underpinnings, and brain-behavior relationships, the review underscores the interdependence between cognitive and emotional processes. Further, it evaluates standard and emerging neuropsychological assessment tools, including neuroimaging and digital platforms, and outlines intervention strategies ranging from cognitive rehabilitation and psychotherapy to pharmacological and integrative care models. Limitations in cultural adaptation, technological implementation, and longitudinal tracking are discussed alongside future research directions emphasizing AI, genomics, and personalized medicine. The findings advocate for a multidisciplinary and patient-centered approach to neuropsychological care, which is essential for enhancing quality of life in individuals affected by CNDs.

## Linked entities

- **Diseases:** Alzheimer’s disease (MONDO:0004975), Parkinson’s disease (MONDO:0005180), epilepsy (MONDO:0005027), multiple sclerosis (MONDO:0005301), stroke (MONDO:0005098), traumatic brain injury (MONDO:0858950)

## Full-text entities

- **Diseases:** multiple sclerosis (MESH:D009103), mood dysregulation (MESH:D019964), Cognitive and Emotional Impairments (MESH:D003072), emotional disturbances (MESH:D014832), neurological deterioration (MESH:D009422), stroke (MESH:D020521), anxiety (MESH:D001007), Parkinson's disease (MESH:D010300), epilepsy (MESH:D004827), CNDs (MESH:D009461), Alzheimer's disease (MESH:D000544), depression (MESH:D003866), traumatic brain injury (MESH:D000070642)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12579567/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12579567/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12579567/full.md

---
Source: https://tomesphere.com/paper/PMC12579567